Michael J. Lee

Dr. Lee is originally from New Hampshire and earned a BS degree in biochemistry from the University of New Hampshire and a PhD degree in Neuroscience at the University of Colorado Health Sciences Center (UCHSC) in Denver, CO. Prior to earning his PhD, he was employed at Xenometrix, Inc., in Boulder, CO, a biotechnology start-up company, developing cell- and gene expression-based toxicity assays. Dr. Lee completed a post-doctoral training fellowship at UCHSC School of Pharmacy utilizing genetically selected inbred mice to identify candidate genes underlying rapid behavioral tolerance to alcohol. Dr. Lee completed post-doctoral work at the Institute for Behavioral Genetics (IBG) at the University of Colorado in Boulder, CO, studying complex behavioral traits related to drugs of abuse utilizing nicotinic receptor knock-out animals. Dr. Lee has published peer-reviewed research articles in the areas of molecular toxicology, pharmacology, behavioral genetics and schizophrenia.

Prior to coming to PCOM in 2011, Dr. Lee held a faculty appointment in the Department of Pharmaceutical Sciences at the Appalachian College of Pharmacy (ACP), in Oakwood, VA. He taught several courses including cell biology, biochemistry, pharmacology and immunology. In addition to his faculty appointment, he served two years as Assistant Dean of Student and Alumni Affairs at ACP overseeing admissions, academic support services, and career and professional development of pharmacy students.